• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cervical cancer screening in Sweden.

作者信息

Dillner J

机构信息

Karolinska Institutet, Microbiology and Tumour Biology Centre (MTC), PO Box 280, S-171 77, Stockholm, Sweden.

出版信息

Eur J Cancer. 2000 Nov;36(17):2255-9. doi: 10.1016/s0959-8049(00)00320-8.

DOI:10.1016/s0959-8049(00)00320-8
PMID:11072216
Abstract

Organised cervical cancer screening was implemented in Sweden in the mid-1960s. A marked decline in cervical cancer incidence could be attributed to the time-point of start of screening. Squamous cell carcinoma has declined by 60%, whereas adenocarcinoma has increased. About 950000 papanicolaou (Pap) smears are taken annually. Only 31% of the smears taken in the organised screening programme. As of 1998, the screening guidelines are 3-yearly tests between 23 and 50 years of age and 5-yearly tests between 50 and 60 years of age. The article reviews the screening practise in Sweden, the current efforts to improve the quality of the screening programme, as well as the ongoing randomised evaluations of organised primary screening for cervical human papilloma virus (HPV) infection.

摘要

相似文献

1
Cervical cancer screening in Sweden.
Eur J Cancer. 2000 Nov;36(17):2255-9. doi: 10.1016/s0959-8049(00)00320-8.
2
Organised screening for cervical cancer in France: a cost-effectiveness assessment.法国宫颈癌的组织性筛查:一项成本效益评估。
BMJ Open. 2017 Oct 6;7(10):e014626. doi: 10.1136/bmjopen-2016-014626.
3
Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua.尼加拉瓜公共卫生系统中基于人乳头瘤病毒的宫颈癌筛查的成本效益
BMJ Open. 2017 Jun 15;7(6):e015048. doi: 10.1136/bmjopen-2016-015048.
4
Impact of patient adherence and test performance on the cost-effectiveness of cervical cancer screening in developing countries: the case of Honduras.发展中国家宫颈癌筛查的成本效益受患者依从性和检测性能的影响:以洪都拉斯为例。
Womens Health Issues. 2010 Jan-Feb;20(1):35-42. doi: 10.1016/j.whi.2009.09.001. Epub 2009 Nov 26.
5
Pap smear screening and changes in cervical cancer mortality in Sweden.瑞典的巴氏涂片筛查与宫颈癌死亡率的变化
Int J Gynaecol Obstet. 1994 Mar;44(3):267-72. doi: 10.1016/0020-7292(94)90177-5.
6
Accuracy of HPV testing of vaginal smear obtained with a novel self-sampling device.使用新型自我采样装置获取的阴道涂片进行HPV检测的准确性。
Acta Obstet Gynecol Scand. 2007;86(1):16-21. doi: 10.1080/00016340601033667.
7
Benefits and costs of using HPV testing to screen for cervical cancer.使用人乳头瘤病毒(HPV)检测筛查宫颈癌的益处与成本
JAMA. 2002 May 8;287(18):2372-81. doi: 10.1001/jama.287.18.2372.
8
Colposcopy for cervical squamous intraepithelial lesions found on Papanicolaou smear.对巴氏涂片检查发现的宫颈鳞状上皮内病变进行阴道镜检查。
Arch Fam Med. 1996 Nov-Dec;5(10):582-4. doi: 10.1001/archfami.5.10.582.
9
Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.基线细胞学检查、人乳头瘤病毒检测与宫颈肿瘤发生风险:一项10年队列分析
J Natl Cancer Inst. 2003 Jan 1;95(1):46-52. doi: 10.1093/jnci/95.1.46.
10
Cost-effectiveness of the conventional papanicolaou test with a new adjunct to cytological screening for squamous cell carcinoma of the uterine cervix and its precursors.传统巴氏试验联合一种用于子宫颈鳞状细胞癌及其前驱病变细胞学筛查的新辅助方法的成本效益分析。
Arch Fam Med. 2000 Aug;9(8):713-21. doi: 10.1001/archfami.9.8.713.

引用本文的文献

1
A comparative analysis of cervical cancer prevention between Nigeria and Nordic countries that have experienced a decline in cervical cancer incidence.中尼宫颈癌防治比较分析及对北欧国家宫颈癌发病率下降的启示
Int Health. 2021 Jul 3;13(4):307-317. doi: 10.1093/inthealth/ihaa062.
2
Cervical screening and risk of adenosquamous and rare histological types of invasive cervical carcinoma: population based nested case-control study.宫颈筛查与宫颈浸润性腺鳞癌及罕见组织学类型的风险:基于人群的巢式病例对照研究。
BMJ. 2019 Apr 3;365:l1207. doi: 10.1136/bmj.l1207.
3
Participation in a Swedish cervical cancer screening program among women with psychiatric diagnoses: a population-based cohort study.
参与瑞典宫颈癌筛查计划的精神科诊断女性:一项基于人群的队列研究。
BMC Public Health. 2019 Mar 18;19(1):313. doi: 10.1186/s12889-019-6626-3.
4
Estimation of the individual residual risk of cervical cancer after vaccination with the nonavalent HPV vaccine.九价人乳头瘤病毒疫苗接种后宫颈癌个体残余风险的估计。
Hum Vaccin Immunother. 2018 Jul 3;14(7):1800-1806. doi: 10.1080/21645515.2018.1450125. Epub 2018 May 24.
5
Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden.根据筛查史评估60岁及以上女性宫颈筛查的有效性:瑞典全国队列研究
PLoS Med. 2017 Oct 24;14(10):e1002414. doi: 10.1371/journal.pmed.1002414. eCollection 2017 Oct.
6
Community collaboration to increase foreign-born women's participation in a cervical cancer screening program in Sweden: a quality improvement project.瑞典开展社区合作以提高外国出生女性参与宫颈癌筛查项目的比例:一项质量改进项目。
Int J Equity Health. 2014 Aug 9;13:62. doi: 10.1186/s12939-014-0062-x.
7
Immigrant women's experiences and views on the prevention of cervical cancer: a qualitative study.移民女性对宫颈癌预防的经历和看法:一项定性研究。
Health Expect. 2015 Jun;18(3):344-54. doi: 10.1111/hex.12034. Epub 2012 Dec 16.
8
Cervical cancer in the screening era: who fell victim in spite of successful screening programs?筛查时代的宫颈癌:尽管筛查项目取得成功,但谁成为了牺牲品?
J Gynecol Oncol. 2011 Jun 30;22(2):76-82. doi: 10.3802/jgo.2011.22.2.76.
9
Cells and the (imaginary) patient: the multistable practitioner-technology-cell interface in the cytology laboratory.
Med Health Care Philos. 2012 Aug;15(3):295-308. doi: 10.1007/s11019-011-9325-0.
10
Modelling the impact of population-based cytologic screening on cervical cancer incidence and mortality in Hong Kong: an age--period--cohort approach.基于人群的细胞学筛查对香港宫颈癌发病率和死亡率影响的建模:年龄-时期-队列方法。
Br J Cancer. 2005 Oct 31;93(9):1077-83. doi: 10.1038/sj.bjc.6602805.